Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

myelodysplastic syndrome with ring sideroblasts (AISA) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

myelodysplastic syndrome with ring sideroblasts

MONDO:0019157

Also known as:AISAMDS with ring sideroblastsMDS-RS

Find Clinical TrialsTrials

Overview

Acquired idiopathic sideroblastic anemia is one of a group of disorders known as the myelodysplastic syndromes (MDS) characterized by ineffective haemopoiesis affecting one or more blood cell lineages (myeloid, erythroid or megakaryocytic) leading to peripheral blood cytopenias and an increased risk of developing leukemia. Acquired idiopathic sideroblastic anemia is now more commonly referred to as refractory anemia with ringed sideroblasts or the acronym RARS.

Clinical Trials2 registered

Diagnosis

Biomarker and diagnostic research for myelodysplastic syndrome with ring sideroblasts has been reported in the published literature.

Prognosis

Estimated prevalence: 1-9 in 100,000 (Uncommon).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

2 clinical trials registered. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE1, 1 NA. Research is primarily sponsored by academic and government institutions.

50 publications have been identified in PubMed for myelodysplastic syndrome with ring sideroblasts. Research spans Clinical Trial Publication (20%), Basic Science / Preclinical (20%), and Review / Meta-Analysis (18%).

Research Type	Count	% of Total
Clinical study results	10

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 2:49 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:75564

GARD

Genetic and Rare Diseases Info Center

GARD:8249

Questions for Your Care Team

→Are any of the 2 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

myelodysplastic syndrome with ring sideroblasts

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications